GSK, CureVac's next-gen Covid-19 vaccine shows promise in monkey trial

August 16, 2021
GlaxoSmithKline and CureVac said a study on macaque monkeys showed their jointly-developed mRNA Covid-19 vaccine candidate to be "strongly improved" in protecting against the virus compared with CureVac's first attempt.

Post a Comment

No comments

Subscribe to: Post Comments ( Atom )
Powered by Blogger.